financetom
Business
financetom
/
Business
/
BRIEF-ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
Jul 9, 2024 6:17 AM

July 9 (Reuters) - ReShape Lifesciences Inc ( RSLS ):

* RESHAPE LIFESCIENCES® ENTERS INTO MERGER AGREEMENT WITH

VYOME

THERAPEUTICS AND ASSET PURCHASE AGREEMENT WITH BIORAD MEDISYS

* RESHAPE LIFESCIENCES INC ( RSLS ): TO SELL ITS ASSETS TO AFFILIATE

OF

BIORAD MEDISYS FOR $5.16 MILLION

* RESHAPE LIFESCIENCES INC ( RSLS ) - EXISTING CO STOCKHOLDERS TO OWN

11.1%

OF COMBINED COMPANY

Source text for Eikon:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Wall Financial Q4 Profit Drops, Revenue Rises
Wall Financial Q4 Profit Drops, Revenue Rises
Apr 29, 2024
06:26 AM EDT, 04/29/2024 (MT Newswires) -- Wall Financial ( WFICF ) , a British Columbia-based real estate company, over the weekend reported fourth-quarter net earnings attributable to shareholders of $551,495, or $0.02 per share, down from $1.7 million, or $0.05 per share, a year earlier. Total revenue and other income for the quarter ended Jan. 31, was $33.3 million,...
US FDA approves X4 Pharmaceuticals' drug for immunodeficiency disease
US FDA approves X4 Pharmaceuticals' drug for immunodeficiency disease
Apr 29, 2024
April 29 (Reuters) - The U.S. FDA has approved X4 Pharmaceuticals' ( XFOR ) drug to treat a rare genetic immunodeficiency disease, the company said on Monday. (Reporting by Christy Santhosh in Bengaluru; Editing by Shinjini Ganguli) ...
Philips Settles US Sleep Therapy Litigation for $1.1 Billion; Reaffirms 2024 Comparable Sales Outlook
Philips Settles US Sleep Therapy Litigation for $1.1 Billion; Reaffirms 2024 Comparable Sales Outlook
Apr 29, 2024
06:35 AM EDT, 04/29/2024 (MT Newswires) -- Royal Philips' (PHG) US-listed shares surged early Monday after reaching a $1.1 billion settlement related to personal injury litigation in the US, while the Dutch health technology firm reiterated its full-year comparable sales growth outlook. The settlement resolves all claims filed in the US over Philips' recalled sleep and respiratory care products, with...
West Red Lake Gold Updates Mineral Resource Estimate for Rowan Mine Deposit in Ontario
West Red Lake Gold Updates Mineral Resource Estimate for Rowan Mine Deposit in Ontario
Apr 29, 2024
06:35 AM EDT, 04/29/2024 (MT Newswires) -- West Red Lake Gold Mines ( WRLGF ) over the weekend said it updated its mineral resource estimate as of March 1 on its Rowan mine deposit in the Red Lake Gold District of northwestern Ontario in Canada. The 2024 mineral resource estimate has added a significant portion of higher confidence indicated ounces...
Copyright 2023-2026 - www.financetom.com All Rights Reserved